0000000001227911
AUTHOR
A. Lombardi
showing 4 related works from this author
“Rationally Local”: Consumer Participation in Alternative Food Chains
2015
Why are consumers increasingly participating in alternative food chains to co-produce and distribute foods with farmers? In this paper, values and food-related lifestyles, as well as transaction costs and socio-demographics, are used to analyze consumer participation in alternative food chains in Italy. Using a simultaneous system of equations, a model with instrumental variables is implemented to measure the relationships between values and food-related lifestyles, and between the latter and participation in an alternative food chain. Our results show that Italian participants in alternative food chains have the profile of rational shoppers who typically look at price and taste criteria. A…
Towards the european strategy for particle physics: The briefing book
2007
This document was prepared as part of the briefing material for the Workshop of the CERN Council Strategy Group, held in DESY Zeuthen from 2nd to 6th May 2006. It gives an overview of the physics issues and of the technological challenges that will shape the future of the field, and incorporates material presented and discussed during the Symposium on the European Strategy for Particle Physics, held in Orsay from 30th January to 2nd February 2006, reflecting the various opinions of the European community as recorded in written submissions to the Strategy Group and in the discussions at the Symposium.
Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016
2018
In Italy, rifampicin-resistant and MDR-TB were high in foreign-born persons, but decreased from 2009 to 2016
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data
2019
OBJECTIVE:\ud We estimated the cost consequence of Italian National Health System (NHS) investment in direct-acting antiviral (DAA) therapy according to hepatitis C virus (HCV) treatment access policies in Italy.\ud \ud METHODS:\ud A multistate, 20-year time horizon Markov model of HCV liver disease progression was developed. Fibrosis stage, age and genotype distributions were derived from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER) cohort. The treatment efficacy, disease progression probabilities and direct costs in each health state were obtained from the literature. The break-even point in time (BPT) was defined as the period of time required for the cumulativ…